Life ScienceCompany
Organovo - FXR program Ownership
Who owns Organovo - FXR program?
Organovo - FXR program is owned by Eli Lilly. It was acquired on February 25, 2025.
Organovo - FXR program Business Overview
Where is Organovo - FXR program headquartered?
Organovo - FXR program is headquartered in San Diego, California.
What sector is Organovo - FXR program in?
Organovo - FXR program is a life science company.
Life Science M&A Summary in 2025
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2025. The largest life science acquisition in 2025 was Intra-Cellular Therapies - which was acquired by Johnson & Johnson for $14.6B.
Join Mergr to view all 62 acquisitions of life science companies in 2025, including 3 acquisitions by private equity firms, and 59 by strategics.